HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

1,465.971

+25.2121.75%

Number of Gainers:4

Number of Losers:6

Number of Flat:3

PE:- -

High:1,473.594

Open:1,441.486

Low:1,412.502

Close:1,440.759

Volume:128.81M

Turnover:2.14B

Market Cap:240.51B

Float Cap:177.31B

Loading ...

Sihuan Pharmaceutical Announces Spin-Off and Separate Listing of Xuanzhu Biopharm on Hong Kong Stock Exchange

Alma, a Sisram Medical Company, Announces Strategic Collaboration With Celebrity Skin Expert Nurse Jamie to Expand Global Consumer Presence

THOMSON REUTERS

SISRAM MED (01696) Subsidiary Enters Strategic Partnership with International Skincare Expert Jamie Sherrill

Alma Lasers Ltd., Subsidiary of Sisram Medical, Announces Strategic Partnership with Nurse Jamie

CMB International Slightly Lowers 3SBIO Target Price to HK$37.58, Maintains Buy Rating

Hong Kong Stock Alert | 3SBIO (01530) Surges Over 3% Again as Institutions Highlight Project 707 Global Clinical Trial Launch as Key Profit Catalyst

BUZZ-Sihuan Pharma hits 3-1/2-year peak on share buyback, growth optimism

Angelalign Technology Inc. Announces Expansion Through Investment in Connected Entity

SIHUAN PHARM (00460) Repurchases 13.096 Million Shares for HK$19.572 Million on September 2

Sihuan Pharmaceutical Files Next Day Disclosure with HKEX, Announces Repurchase of 13,096,000 Shares at HKD 19.57 Million

Fosun Pharmaceutical Gets US FDA's Nod for Osteoporosis Drug

MT Newswires Live

BlackRock Increases Holdings in 3SBIO by 47.6 Million Shares at Approximately HK$30.11 Per Share

AH Stock Statistics | September 1

Xuanzhu Biology Plans Hong Kong IPO, Receives CSRC Filing Notice

SIHUAN PHARM (00460) Plans to Establish AI R&D Company with Shenyuanzhi Pharmaceutical to Jointly Explore AI-Driven Medical Aesthetics Product Development

Sihuan Pharmaceutical Partners with dProtein to Launch AI-Driven Medical Aesthetic R&D Company

Sihuan Pharmaceutical - Jointly Established AI R+D Co With Units to Explore Development of AI-Driven Novel Medical Aesthetic Products

THOMSON REUTERS

3SBio Inc. Reports 24.6% YOY Increase in Net Profit and 11.6% YOY Increase in EBITDA for 2025 Interim Results

RAILY AESMED (02135) Reports Interim Results: Shareholder Loss of HK$7.57 Million, Up 368.15% YoY

Raily Aesthetic Medicine International Holdings H1 Gross Profit RMB 29.1 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1593/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":1465.9714,"timestamp":1757405290965,"preClose":1440.759,"halted":0,"volume":128805171,"delay":0,"changeRate":0.017499,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":25.212402,"latestTime":"09-09 16:00:00","open":1441.4856,"high":1473.5939,"low":1412.5018,"amount":2139217392,"amplitude":0.042403,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"pbRate":2.085437,"peRate":29.311372,"turnoverRate":0.006228,"increases":4,"decrements":6,"flats":3,"marketCap":240505319816,"floatMarketCap":177312741768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":1473.5939,"amplitude":0.042403,"preClose":1440.759,"low":1412.5018,"pbRate":"2.085437","latestPrice":1465.9714,"volume":128805171,"delay":0,"open":1441.4856,"prevYearClose":571.87146,"prevWeekClose":1420.862,"prevMonthClose":1253.623,"prevQuarterClose":1037.486,"fiveDayClose":1314.432,"twentyDayClose":1260.192,"sixtyDayClose":1033.634,"secType":"PLATE","market":"HK","turnoverRate":0.006228,"peRate":29.311372,"marketCap":240505319816,"floatMarketCap":177312741768,"timestamp":1757405290965,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564087413","title":"Sihuan Pharmaceutical Announces Spin-Off and Separate Listing of Xuanzhu Biopharm on Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2564087413","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564087413?lang=en_us&edition=fundamental","pubTime":"2025-09-04 22:25","pubTimestamp":1756995902,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. has announced the spin-off and separate listing of Xuanzhu Biopharmaceutical Co., Ltd. on the Main Board of the Stock Exchange of Hong Kong Limited. The listing involves SpinCo H Shares, which are overseas listed foreign shares in the ordinary share capital of Xuanzhu Biopharm, with a nominal value of RMB1.00 each. These shares are to be subscribed for and traded in Hong Kong dollars. The Record Date for determining Qualifying Shareholders' assured entitlement to the SpinCo Shares in the Global Offering is set for September 18, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief on Septemb","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL8P26TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1600","00460","BK1191","BK1593"],"gpt_icon":0},{"id":"2564864308","title":"Alma, a Sisram Medical Company, Announces Strategic Collaboration With Celebrity Skin Expert Nurse Jamie to Expand Global Consumer Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2564864308","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564864308?lang=en_us&edition=fundamental","pubTime":"2025-09-04 22:00","pubTimestamp":1756994410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nTUA6VPMXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1585","BK1100","BK1593","01696"],"gpt_icon":0},{"id":"1141687272","title":"SISRAM MED (01696) Subsidiary Enters Strategic Partnership with International Skincare Expert Jamie Sherrill","url":"https://stock-news.laohu8.com/highlight/detail?id=1141687272","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141687272?lang=en_us&edition=fundamental","pubTime":"2025-09-04 17:48","pubTimestamp":1756979322,"startTime":"0","endTime":"0","summary":"SISRAM MED (01696) announced that its wholly-owned subsidiary Alma Lasers Ltd. (Alma), a provider of energy-based aesthetic medical equipment solutions, has entered into a strategic partnership with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01696","BK1593","BK1585","BK1100"],"gpt_icon":0},{"id":"2564378526","title":"Alma Lasers Ltd., Subsidiary of Sisram Medical, Announces Strategic Partnership with Nurse Jamie","url":"https://stock-news.laohu8.com/highlight/detail?id=2564378526","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564378526?lang=en_us&edition=fundamental","pubTime":"2025-09-04 17:45","pubTimestamp":1756979151,"startTime":"0","endTime":"0","summary":"Sisram Medical Ltd. has announced a strategic collaboration involving its wholly-owned subsidiary, Alma Lasers Ltd. Alma, which specializes in energy-based medical and aesthetic solutions, is partnering with Jamie Sherrill, also known as \"Nurse Jamie,\" a globally recognized skin-care expert and entrepreneur in the aesthetics sector. The partnership aims to enhance consumer engagement and reinforce Alma's leadership in premium aesthetic technologies. Jamie Sherrill will act as a strategic representative for Alma's flagship platforms, including Alma Harmony and Opus. This collaboration is expected to raise awareness and accelerate the adoption of Alma's solutions in consumer markets, creating stronger demand and new growth opportunities for clinic partners worldwide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDLPdzr2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01696","BK1230","BK1100","BK1593","00656","BK1585"],"gpt_icon":0},{"id":"1173809170","title":"CMB International Slightly Lowers 3SBIO Target Price to HK$37.58, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1173809170","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173809170?lang=en_us&edition=fundamental","pubTime":"2025-09-03 17:00","pubTimestamp":1756890021,"startTime":"0","endTime":"0","summary":"CMB International released a research report stating that the launch of 3SBIO's (01530) 707 global clinical trial is expected to serve as an important catalyst for the group's profit growth. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1161","BK1593","BK1583"],"gpt_icon":1},{"id":"1172644790","title":"Hong Kong Stock Alert | 3SBIO (01530) Surges Over 3% Again as Institutions Highlight Project 707 Global Clinical Trial Launch as Key Profit Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1172644790","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172644790?lang=en_us&edition=fundamental","pubTime":"2025-09-03 11:00","pubTimestamp":1756868429,"startTime":"0","endTime":"0","summary":"3SBIO (01530) continued its upward momentum, rising over 3% in Hong Kong trading. As of press time, the stock gained 3.61% to HK$32.16, with trading volume reaching HK$584 million. China Merchants...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1161","BK1593","BK1583"],"gpt_icon":1},{"id":"2564353887","title":"BUZZ-Sihuan Pharma hits 3-1/2-year peak on share buyback, growth optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2564353887","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564353887?lang=en_us&edition=fundamental","pubTime":"2025-09-03 10:22","pubTimestamp":1756866138,"startTime":"0","endTime":"0","summary":"BUZZ-Sihuan Pharma hits 3-1/2-year peak on share buyback, growth optimism ** Shares of Sihuan Pharmaceutical Holdings Group 0460.HK jump 9.3% to HK$1.64, their highest level since February 2022 ** Stock marks its biggest intraday pct rise since July 14, and is second-biggest pct gainer in the healthcare index .HSCIH, which rises 1.6% ** Company said it had on September 2 repurchased 13.1 million shares in the open market at an average price of HK$1.4945 apiece for HK$19.6 million  ** Sihuan says it has made positive progresses in new businesses of medical aesthetics and innovative pharmaceuticals and it expects launch of a large number of flagship new products to bring strong momentum to future revenue and profit growth** Hang Seng Biotech Index .HSHKBIO rises 1.7%, benchmark Hang Seng Index .HSI adds 0.03%** YTD, Sihuan stock up 143.9%, Hang Seng Index up 27.2%     ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nL1N3UQ01N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","00460","BK1600","BK1191"],"gpt_icon":0},{"id":"2564803779","title":"Angelalign Technology Inc. Announces Expansion Through Investment in Connected Entity","url":"https://stock-news.laohu8.com/highlight/detail?id=2564803779","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564803779?lang=en_us&edition=fundamental","pubTime":"2025-09-02 18:12","pubTimestamp":1756807978,"startTime":"0","endTime":"0","summary":"Angelalign Technology Inc., a leading company in orthodontic technology, has announced its expansion through a strategic investment in a connected entity. This move, disclosed in a supplemental announcement, highlights the company's commitment to broadening its influence in the medical device sector. The investment involves collaboration with existing shareholders, including Premier MedTec Group Limited and several independent third-party individuals. The expansion aligns with Angelalign's growth strategy, leveraging partnerships to enhance its market presence and technological advancements. The company, incorporated in the Cayman Islands, continues to solidify its position as a key player in the orthodontic technology industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDLbJLqvy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1587","BK1100","06699","BK1583"],"gpt_icon":0},{"id":"1166044561","title":"SIHUAN PHARM (00460) Repurchases 13.096 Million Shares for HK$19.572 Million on September 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1166044561","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166044561?lang=en_us&edition=fundamental","pubTime":"2025-09-02 17:46","pubTimestamp":1756806375,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that on September 2, 2025, the company spent HK$19.572 million to repurchase 13.096 million shares at prices ranging from HK$1.48 to HK$1.51 per share.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1515","BK1593","BK1600"],"gpt_icon":0},{"id":"2564430808","title":"Sihuan Pharmaceutical Files Next Day Disclosure with HKEX, Announces Repurchase of 13,096,000 Shares at HKD 19.57 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2564430808","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564430808?lang=en_us&edition=fundamental","pubTime":"2025-09-02 17:41","pubTimestamp":1756806107,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange. The company reported the repurchase of 13,096,000 ordinary shares, held as treasury shares, at an aggregate price of HKD 19,571,972, with a volume-weighted average repurchase price per share of HKD 1.4945.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief on September 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL9MQKl7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1600","BK1593","BK1191","00460"],"gpt_icon":0},{"id":"2564824656","title":"Fosun Pharmaceutical Gets US FDA's Nod for Osteoporosis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2564824656","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564824656?lang=en_us&edition=fundamental","pubTime":"2025-09-02 10:34","pubTimestamp":1756780489,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (HKG:2196, SHA:600196), through unit Shanghai Henlius Biotech, received approval from the US Food and Drug Administration for the biologics license applications of denosu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","BK0096","BK0012","600196","BK0028","00656","BK0188","BK0196","BK0239","BK0175","BK0183","BK1191","BK1515","BK0060","BK0187","02196","BK1230"],"gpt_icon":0},{"id":"1159467965","title":"BlackRock Increases Holdings in 3SBIO by 47.6 Million Shares at Approximately HK$30.11 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1159467965","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159467965?lang=en_us&edition=fundamental","pubTime":"2025-09-02 08:11","pubTimestamp":1756771873,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on August 26, BlackRock increased its holdings in 3SBIO (01530) by 47.60475 million shares at HK$30.1096 per share, with a total value...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1161","LU0648001328.SGD","IE00B42XCP33.USD","LU0157215616.USD","LU0320765489.SGD","LU1599440770.SGD","BK4534","LU2592432038.USD","IE00B3PB1722.GBP","BK1593","LU2430703251.USD","LU0731783048.USD","LU0980610538.SGD","LU0731783394.SGD","BK4533","LU0640476718.USD","LU1064131342.USD","LU1366333091.USD","LU1481011911.USD","IE00BGHQF631.EUR","LU1670627923.USD","BLK","LU2505996509.AUD","LU0130102774.USD","LU2430703178.SGD","01530","BK1583","LU0070302665.USD","LU1280957306.USD","LU1989771016.USD","LU2264538146.SGD","LU1509826696.USD","BK4567","LU2430703095.HKD","BK4135","LU1481011671.HKD","BK4535","LU1074936037.SGD","LU0772969993.USD","IE00B64PRP62.GBP","LU0742537680.HKD","BK4588","BK4504","BK4581","LU0208291251.USD","LU1291159041.SGD","IE00BVYPNW00.USD","LU2505996681.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU1201861249.SGD","LU1988902786.USD","IE00BVYPNV92.GBP","LU1670628061.USD","IE00BDGV0183.EUR"],"gpt_icon":0},{"id":"1175864582","title":"AH Stock Statistics | September 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1175864582","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175864582?lang=en_us&edition=fundamental","pubTime":"2025-09-01 16:16","pubTimestamp":1756714615,"startTime":"0","endTime":"0","summary":"As of the close on September 1st, NE ELECTRIC (00042), HOLLY FUTURES (03678), and ANDRE JUICE (02218) ranked as the top three in AH premium rates, with premiums of 785.25%, 247.54%, and 235.17%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BK1610","LU0823414478.USD","SG9999015986.USD","LU1497733557.USD","00956","LU1813983027.USD","IE00B543WZ88.USD","LU0117841782.USD","LU0865486749.SGD","BK1514","BK1540","LU0456827905.SGD","LU0650527681.SGD","LU1008478684.HKD","LU0345780281.USD","01057","LU0828237510.HKD","LU0163747925.USD","LU1655091616.SGD","81211","LU0516422366.SGD","LU0918141887.USD","HK0000320264.USD","IE0034224299.USD","LU0561508036.HKD","BK1116","BK1144","LU0791590937.USD","BK1237","LU0828238088.HKD","LU1152091754.HKD","LU0823040885.USD","601633","BK1563","LU0289739343.SGD","LU2226246903.HKD","LU1282649141.HKD","BK1582","LU0868486357.SGD","HK0000252160.HKD","LU0061477393.USD","01033","LU1960683339.HKD","01349","BK1171","BK1135","06127","IE00BYV24P56.USD","LU0509642566.USD","LU0348805143.USD","IE0008368742.USD","LU2097828631.EUR","LU0244354667.USD","LU0456846285.SGD","BK1127","BK1513","LU1224709979.USD","LU1808992512.USD","LU0417516738.SGD","BK1521","LU0589944569.HKD","LU1794554557.SGD","LU0531970944.HKD","01339","LU0511384066.AUD","LU0289961442.SGD","BK1592","LU0231483743.USD","LU0348788117.USD","LU0370786039.SGD","LU2449936058.SGD","LU1251922891.USD","LU0449509016.USD","LU1720050803.USD","LU0797268264.HKD","LU0449515922.USD","HK0000252152.HKD","LU2357125470.USD","BK1125","IE00BVYPNQ40.USD","LU2039709279.SGD","LU1303224171.USD","LU0348827113.USD","LU0214875030.USD","00300","SG9999004220.SGD","00916","LU2294711713.HKD","LU1880383440.USD","BK1119","LU0106959298.USD","02338","LU0594300179.USD","LU2097828557.USD","LU2543165471.USD","01211","LU0886674414.USD","LU2125910500.SGD","LU0502904849.HKD","BK1183","SG9999001226.SGD","LU0593848301.USD","LU0181495838.USD","LU0269904917.USD","LU0819123356.HKD","LU2348774022.SGD","IE00B0169L03.USD","BK1148","LU0384037296.USD","BK1583","BK1507","LU0572944931.SGD","LU0588545490.SGD","LU2148510915.USD","SG9999002950.SGD","BK1515","BK1141","LU1242518857.USD","82333","LU0211977185.USD","LU0067412154.USD","LU0431992006.USD","02359","LU0228659784.USD","LU0289960550.SGD","LU1497733631.SGD","LU1242518931.SGD","BYDDY","LU0791591158.USD","02039","LU0588546209.SGD","LU0326950275.SGD","399300","LU1105468828.SGD","BK1105","IE00B031HY20.USD","BK1503","LU1807302812.USD","LU0345780521.USD","LU0417516902.SGD","LU1282649810.SGD","LU0823426480.USD","LU1188198961.HKD","LU1115378108.SGD","IE00BF5LJ272.USD","LU0543330566.HKD","LU1719994722.HKD","LU1366334651.USD","BK1593","LU0348814723.USD","SG9999006514.SGD","LU0880133367.SGD","BK1562","IE00BD6J9T35.USD","HK0000320223.HKD","BK1225","BK1551","LU0048580855.USD","LU0588545730.USD","BK1537","LU0594300419.USD","LU0488056044.USD","LU0648948544.HKD","LU0856984785.SGD","00042","03143","LU1023057109.AUD","LU1211504680.USD","00187","LU0229945570.USD","LU1861219969.SGD","LU1226287529.USD","BK1594","LU0254981946.USD","LU0039217434.USD","BK1564","LU0823039010.USD","LU0320764599.SGD","LU1497734951.SGD","LU0469268626.HKD","LU2399975544.HKD","LU0228367735.SGD","03750","BK1568","LU1282651048.USD","LU0106252389.USD","HK0000306685.HKD","BK1522","01812","LU1046422090.SGD","SG9999014674.SGD","SG9999015978.USD","LU0823038988.USD","00358","LU1504937902.USD","LU2476274308.USD","LU0143863198.USD","LU0043850808.USD","LU1328615791.USD","BK1530","BK1550","LU0084288322.USD","BK1231","LU1282651121.HKD","LU0516422952.EUR","LU1880383366.USD","LU1831875114.USD","LU0348735423.USD","LU0405327494.USD","BK1552","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","BK1154","BK1554","IE0031814852.USD","BK1198","LU0173614495.USD","LU0588545904.SGD","LU0821914370.USD","LU0359201612.USD","LU0259732245.USD","LU1868837565.USD","LU0501845795.SGD","LU0327786744.USD","SG9999006597.SGD","LU1770034418.SGD","LU0143863784.USD","01618","HK0000306701.USD","03968","06178","LU0828237940.HKD","BK1560","LU0737861699.HKD","LU1328277881.USD","00991","LU2778985437.USD","SG9999015952.SGD","LU2249611893.SGD","IE00B29SXG58.USD","01276","LU1224444064.USD","BK1166","LU0054450605.USD","HK0000500386.USD","BK1202","LU1048596156.SGD","02333","BK1191","LU0823426308.USD","LU0819121731.USD","01108","LU0314109678.HKD","BK1576","IE00BVYPNP33.GBP","BK1544","LU0072913022.USD","LU0516422440.USD","LU1634259391.SGD","LU2045819591.USD","LU0505663152.USD","LU0315178854.USD","LU2153592121.USD","BK1140","SG9999002463.SGD","LU1993786604.SGD","03678","LU0140636845.USD","LU2476274720.SGD","LU1064131003.USD","BK1546","LU1522347837.USD","00914","SG9999002828.SGD","LU1688375341.USD","LU0708995583.HKD","BK1505","BK1147","LU1868837722.USD","LU1861214812.USD","002594","LU0051755006.USD","LU0979878070.USD","IE00BGHQDM52.EUR","LU0164872284.USD","LU2097828714.EUR","LU0605514214.HKD","LU2242644610.SGD","LU0348825331.USD","HYDD.SI","LU0096374516.USD","LU0890818403.SGD","BK1214","IE00B031J352.USD","159982","LU1961090484.USD","LU0165289439.USD","LU1152091168.USD","LU0164865239.USD","LU0862451753.SGD","LU0531971595.HKD","LU2360107325.USD","IE00B3M56506.USD","03606","LU1064130708.USD","LU0359201885.HKD","LU0918141705.HKD","00323","LU0455707207.USD","LU0348816934.USD","LU1282648689.USD","LU0405327148.USD","LU1675838814.USD","LU0516423174.USD","02196","LU0516423091.SGD","LU0307460666.USD","LU1868838027.USD","LU1634259557.SGD","SG9999015945.SGD","LU0293314216.USD","BK1565","LU1366334578.USD","LU0871576103.HKD","IE0008369823.USD","LU0359202008.SGD","LU0463099449.HKD","06680","LU0287142896.SGD","LU0823414551.USD","LU0634319403.HKD","BK1110","LU0175139822.USD","00895","BK1509","LU2506951792.HKD","02899","LU0540923850.HKD","BK1539","GWLLY","02465","LU0052750758.USD","LU2097828474.EUR","IE00BMCWC346.EUR","LU2097828805.USD","LU0315179316.USD","BK1223","IE00BZ08YR35.GBP","LU1282649067.USD","BK1206","LU0640798160.USD","BK1558","02218","LU0049853897.USD"],"gpt_icon":1},{"id":"1161323446","title":"Xuanzhu Biology Plans Hong Kong IPO, Receives CSRC Filing Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1161323446","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161323446?lang=en_us&edition=fundamental","pubTime":"2025-09-01 13:30","pubTimestamp":1756704630,"startTime":"0","endTime":"0","summary":"On August 29, 2025, the International Cooperation Department of the China Securities Regulatory Commission issued a filing notice for Xuanzhu Biotech Co., Ltd.'s overseas issuance and listing and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1600","BK1191","BK1593","00460"],"gpt_icon":0},{"id":"1110221219","title":"SIHUAN PHARM (00460) Plans to Establish AI R&D Company with Shenyuanzhi Pharmaceutical to Jointly Explore AI-Driven Medical Aesthetics Product Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1110221219","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110221219?lang=en_us&edition=fundamental","pubTime":"2025-09-01 12:12","pubTimestamp":1756699957,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that to promote the deep application and industrialization of artificial intelligence (AI) technology in medical aesthetics product research and development, the group...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1593","BK1600","BK1515"],"gpt_icon":0},{"id":"2564860730","title":"Sihuan Pharmaceutical Partners with dProtein to Launch AI-Driven Medical Aesthetic R&D Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2564860730","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564860730?lang=en_us&edition=fundamental","pubTime":"2025-09-01 12:06","pubTimestamp":1756699565,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. has entered into a strategic partnership with dProtein Pharmaceutical Biotechnology  Co., Ltd. to establish an AI R&D company. This collaboration aims to explore the development of innovative medical aesthetic products driven by artificial intelligence technology. The joint venture marks a significant step in Sihuan Pharmaceutical's strategic direction to integrate AI within the medical aesthetic industry, enhancing its competitiveness and market value. Through this alliance, both parties intend to harness technological innovation to meet the growing demands of the medical aesthetic market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the or","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nNDL9fbw4J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1593","BK1600","BK1515"],"gpt_icon":0},{"id":"2564860245","title":"Sihuan Pharmaceutical - Jointly Established AI R+D Co With Units to Explore Development of AI-Driven Novel Medical Aesthetic Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2564860245","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564860245?lang=en_us&edition=fundamental","pubTime":"2025-09-01 12:02","pubTimestamp":1756699324,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UL1GA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1593","BK1191","BK1515","00460"],"gpt_icon":0},{"id":"2564864266","title":"3SBio Inc. Reports 24.6% YOY Increase in Net Profit and 11.6% YOY Increase in EBITDA for 2025 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2564864266","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564864266?lang=en_us&edition=fundamental","pubTime":"2025-09-01 10:30","pubTimestamp":1756693822,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3SBio Inc. published the original content used to generate this news brief on August 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nNDLDRdKn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","01530","BK1583","BK1161"],"gpt_icon":1},{"id":"1120901355","title":"RAILY AESMED (02135) Reports Interim Results: Shareholder Loss of HK$7.57 Million, Up 368.15% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1120901355","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120901355?lang=en_us&edition=fundamental","pubTime":"2025-08-29 20:56","pubTimestamp":1756472190,"startTime":"0","endTime":"0","summary":"RAILY AESMED (02135) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of HK$84.598 million, representing a decrease of 27.99% year-on-year. Loss...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2563155028","title":"Raily Aesthetic Medicine International Holdings H1 Gross Profit RMB 29.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2563155028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563155028?lang=en_us&edition=fundamental","pubTime":"2025-08-29 20:17","pubTimestamp":1756469864,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nPLX4AE6DD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02135","BK1593","BK1209"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":91,"code":"91000000","status":"200"}]}}